Modeling Melanoma Immune Surveillance by CAR-T Cells in Human Skin Organoids

Area of Science:

• Oncology
• Immunology
• Biotechnology

Background:

• T cell-mediated therapies show promise for melanoma treatment but face clinical application challenges.
• Current preclinical models (xenografts, explants, co-cultures) lack the necessary tissue context for melanoma.
• Optimization of T cell-based melanoma therapies requires improved preclinical research models.

Purpose of the Study:

• To develop an advanced preclinical model for evaluating T cell-mediated therapies in melanoma.
• To create a human skin organoid system that accurately mimics the melanoma tumor microenvironment.
• To facilitate the study of primary T cells and chimeric antigen receptor (CAR)-T cells in conjunction with melanoma cells within a relevant tissue context.

Main Methods:

• Generation of human skin organoids from primary epidermal keratinocytes.
• Incorporation of melanoma cells into the skin organoid structure.
• Co-culture of melanoma cells within the organoid with primary T cells and chimeric antigen receptor (CAR)-T cells.

Main Results:

• Successfully established a human skin organoid model containing melanoma cells.
• Demonstrated the integration and interaction of primary T cells and CAR-T cells within the melanoma-bearing organoid.
• The organoid system provides a more physiologically relevant tissue context compared to traditional models.

Conclusions:

• The developed human skin organoid model offers a novel and improved platform for preclinical evaluation of T cell-based melanoma therapies.
• This model overcomes limitations of existing preclinical systems by providing essential tissue context.
• Further research using this organoid system can accelerate the optimization and clinical translation of advanced melanoma treatments.